Eslicarbazepine Acetate (2 brand names, 1 dosage form, 1 route)
Available dosage forms: TABLET.
Routes of administration: ORAL.
Brand Names
- APTIOM
- ESLICARBAZEPINE ACETATE
Indications and Usage
Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Contraindications
Eslicarbazepine acetate tablets are contraindicated in patients with a hypersensitivity to eslicarbazepine acetate or oxcarbazepine [see Warnings and Precautions (5.2, 5.3, and 5.4)].
Adverse Reactions
The following adverse reactions are described in more detail in the Warnings and Precautions section of the label: Suicidal Behavior and Ideation [see Warnings and Precautions (5.1)] Serious Dermatologic Reactions [see Warnings and Precautions (5.2)] Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity [see Warnings and Precautions (5.3)] Anaphylactic Reactions and Angioedema [see Warnings and Precautions (5.4)] Hyponatremia [see Warnings and Precautions (5.5)] Neurological Adverse Reactions [see Warnings and Precautions (5.6)] Drug Induced Liver Injury [see Warnings and Precautions (5.8)] Abnormal Thyroid Function Tests [see Warnings and Precautions (5.9)] Pancytopenia, Agranulocytosis, and Leukopenia [see Warnings and Precautions (5.10)]